ACI Archean Chemical Industries Q3 FY26 results (Oct–Dec 2025) and concall
Archean Chemical reported mixed results for Q3 FY26, with standalone revenue growing 2.4% YoY to INR 2,608.1 million, but EBITDA declining 27% YoY to INR 698.6 million due to operational challenges and cost pressures. While industrial salt and elemental bromine showed strong demand, bromine derivatives faced margin compression, and the SOP project continued to experience delays. The company is actively progressing its strategic initiatives in semiconductors and energy storage.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 2.9%, net profit down 39.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 238 | 243 | 322 | 279 | 221 −7% | 250 +3% |
| EBITDA | 76 | 84 | 90 | 83 | 65 −14% | 59 −30% |
| Net profit | 22 | 56 | 58 | 52 | 38 +73% | 34 −39% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





